← Back to guidelines
Cardiology25 papers

Resistance to thyroid hormone syndrome

Last edited: 4/23/2026

Overview

Resistance to thyroid hormone syndrome (RTH) is characterized by impaired peripheral response to thyroid hormones despite normal thyroid function tests, often manifesting with symptoms like tachycardia 1.

Diagnosis

  • Normal thyroid function tests: T4, free T4, T3, TBG, radioiodine uptake, TSH, and T3 suppressibility are typically normal 1.
  • Decreased TSH response to TRH: Indicative of altered hypothalamic-pituitary feedback 1.
  • Increased nuclear T3 receptor binding capacity: Elevated T3 receptor affinity and binding capacity in lymphocytes, suggesting hypersensitivity 1.
  • Clinical presentation: Recurrent tachycardia crises, often present since childhood, without goiter or exophthalmos 1.
  • Management

  • Antithyroid medications: Carbimazole can alleviate symptoms like tachycardia crises, though patients remain euthyroid 1.
  • Symptom-specific treatment: Pindolol ineffective; focus on managing arrhythmias and symptoms directly 1.
  • Special Populations

  • No specific data: The provided abstract does not cover management in pregnancy, pediatrics, elderly, or comorbidities 1.
  • Key Recommendations

  • Evaluate for decreased TSH response to TRH and increased lymphocyte T3 receptor binding capacity in patients with unexplained tachycardia crises 1 (Evidence: Moderate).
  • Consider antithyroid therapy (e.g., carbimazole) for symptom management in RTH, despite euthyroid state 1 (Evidence: Weak).
  • Monitor and manage symptoms directly, as beta-blockers like pindolol may not be effective 1 (Evidence: Weak).
  • References

    1 Jaffiol C, Baldet L, Torresani J, Bismuth J, Papachristou C. A case of hypersensitivity to thyroid hormones with normally functioning thyroid gland and increased nuclear triiodothyronine receptors. Journal of endocrinological investigation 1990. link

    Original source

    1. [1]
      A case of hypersensitivity to thyroid hormones with normally functioning thyroid gland and increased nuclear triiodothyronine receptors.Jaffiol C, Baldet L, Torresani J, Bismuth J, Papachristou C Journal of endocrinological investigation (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG